Mechanistic study of the bismuth mediated fluorination of arylboronic esters and further rational design.

RSC Adv

Institute of Advanced Synthesis, School of Chemistry and Molecular Engineering, Jiangsu National Synergetic Innovation Center for Advanced Materials, Nanjing Tech University Nanjing 211816 China

Published: August 2022

Density functional theory (DFT) calculations have been performed to gain insight into the catalytic mechanism of the bismuth redox catalyzed fluorination of arylboronic esters to deliver the widely used arylfluoride compounds ( 2020, , 313-317). The study reveals that the whole catalysis can be characterized three stages: (i) transmetallation generates the Bi(iii) intermediate 5, capitalizing on the use of KF as an activator. (ii) 5 then reacts with the electrophilic fluorination reagent 1-fluoro-2,6-dichloropyridinium 4 oxidative addition to give the Bi(v) intermediate IM4A. (iii) IM4A undergoes a reductive elimination step to yield aryl fluoride compounds and regenerates the bismuth catalyst for the next catalytic cycle. Each stage is kinetically and thermodynamically feasible. The transmetallation step, with a barrier of 25.4 kcal mol, is predicted to be the rate-determining step (RDS) during the whole catalytic cycle. Furthermore, based on a mechanistic study, new catalysts with the framework of tethered bis-anionic ligands were designed, which will help to improve current catalytic systems and develop new bismuth mediated fluorination of arylboronic esters.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9404455PMC
http://dx.doi.org/10.1039/d2ra04296gDOI Listing

Publication Analysis

Top Keywords

fluorination arylboronic
12
arylboronic esters
12
mechanistic study
8
bismuth mediated
8
mediated fluorination
8
catalytic cycle
8
bismuth
4
study bismuth
4
fluorination
4
esters rational
4

Similar Publications

Background: Heart-type fatty acid binding proteins (FABP3) constitute a family of lipid chaperone proteins. They are found in the cytosol and enhance cellular fatty acid solubilisation, transport, and metabolism. FABP3 is highly expressed in the myocardium and is released from myocytes during myocardial damage.

View Article and Find Full Text PDF

The indispensability of a base in Suzuki-Miyaura coupling (SMC) employing organoboronic acids/esters is well recognized, which occasionally induces competitive protodeborylation in organoboron reagents. This phenomenon is particularly pronounced in fluorine-substituted aryl and heteroaryl boron compounds. Here, we show that direct SMC of naphthalene-1,8-diaminato (dan)-substituted aryl boron compounds, Ar-B(dan), characterized by its remarkable stability toward protodeborylation due to their diminished boron-Lewis acidity, occurs utilizing a weak base in conjunction with a palladium/copper cooperative catalyst system.

View Article and Find Full Text PDF

A catalytic method for the introduction of pharmaceutically meaningful fluorinated propionic acid side chains into aromatic compounds is presented. In the presence of rhodium catalyst [RhCp*Cl], various arylboronic acids are efficiently coupled with an easy-to-access diazoester reagent to give perfluorinated derivatives of phenylpropionic acids, including top-selling profen drugs. The key advantage of this approach is that the pharmacophore is introduced as a whole and is compatible with various functionalities and drug discovery.

View Article and Find Full Text PDF

Fluorinated arenes play a crucial role in drug discovery, specialty materials, and medical imaging. Although several variants for Cu-mediated nucleophilic fluorination of arylboronic acids and derivatives have been developed, these protocols rarely address the occurrence and control of protodeboronation, which greatly complicates product separation and can compromise the effectiveness of a radiotracer for in vivo imaging. Consequently, simpler and more efficient procedures are needed to allow rapid F/F-fluorination of both arylboronic acids and esters while minimizing protodeboronation.

View Article and Find Full Text PDF

The [F]fluorobenzyltriphenylphosphonium cation ([F]FBnTP) has emerged as a highly promising positron emission tomography (PET) tracer for myocardial perfusion imaging (MPI) due to its uniform distribution in the myocardium and favorable organ biodistribution demonstrated in preclinical studies. However, a complex and low-efficiency radiosynthesis procedure has significantly hindered its broader preclinical and clinical explorations. Recently, Zhang developed a pinacolyl arylboronate precursor, enabling a one-step synthesis process that greatly streamlines the production of [F]FBnTP.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!